ENvue Medical Inc
FEED
10 hedge funds and large institutions have $242K invested in ENvue Medical Inc in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 5 → 10 (+5)
70% more capital invested
Capital invested by funds: $142K → $242K (+$100K)
0.04% more ownership
Funds ownership: 0.02% → 0.07% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$78.6K |
| 2 |
VF
Virtu Financial
New York
|
+$37.2K |
| 3 |
HF
HRT Financial
New York
|
+$35.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$24.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
-$34 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $57.2K | +$78.6K | +264 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $56K | +$31K | +104 | +68% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $28.5K | +$10.1K | +34 | +35% |
|
|
VF
4
Virtu Financial
New York
| $27K | +$37.2K | +125 | New |
|
|
HF
5
HRT Financial
New York
| $25K | +$35.4K | +119 | New |
|
|
AFS
6
Amtrust Financial Services
New York
| $24.4K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $17.5K | +$24.1K | +81 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $6.16K | +$4.76K | +16 | +133% |
|
9
National Bank of Canada
Montreal,
Quebec, Canada
| $190 | +$298 | +1 | New |
|
10
BlackRock
New York
| $146 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $24 | – | – | – |
|
12
Morgan Stanley
New York
| $20 | – | – | – |
|
13
Bank of America
Charlotte,
North Carolina
| $2 | – | – | – |
|
|
NC
14
NewSquare Capital
Newtown Square,
Pennsylvania
| – | -$34 | – | – |
|
FEED Hedge Fund Activity: Q3 2023 in Review
10 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q3 2023, worth a combined $242K — up 70% from $142K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FEED positions and 0 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $78.6K. The largest seller was NewSquare Capital, cutting an estimated $34.
- 10 institutional investors held ENvue Medical Inc (FEED) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $242K of ENvue Medical Inc stock for Q3 2023, up 70% quarter-over-quarter.
- 5 funds opened new ENvue Medical Inc positions in Q3 2023 and 0 closed out, a net change of +5 holders.
- The largest ENvue Medical Inc buyer in Q3 2023 was Armistice Capital, an estimated $78.6K added.
- The largest ENvue Medical Inc seller in Q3 2023 was NewSquare Capital, an estimated $34 sold.
Based on aggregated 13F filings for Q3 2023.